Home Data Calendar Blog

ZYME

Tables

    2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30
Common Stock Value 1003.48997.23932.14929.40900.49886.32885.35NANA741.15NA
Weighted Average Number Of Diluted Shares Outstanding 76.25NA70.5867.2866.74NA66.4866.3561.38NA52.24
Weighted Average Number Of Shares Outstanding Basic 76.21NA70.5867.2866.74NA66.4866.3561.37NA51.66
Earnings Per Share Basic -0.42-0.19-0.41-0.76-0.364.77-0.72-0.97-1.18-0.76-1.17
Earnings Per Share Diluted -0.42-0.19-0.41-0.76-0.374.76-0.72-0.97-1.19-0.95-1.25

    2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30
Revenue From Contract With Customer Excluding Assessed Tax 10.0316.9316.517.0035.58402.492.635.441.9219.874.39
Revenues 10.0316.9316.517.0035.58402.492.635.441.9219.874.39
Costs And Expenses 47.8340.3549.7461.1262.8683.1052.9971.2774.6060.7265.36
Research And Development Expense 32.0425.5232.7739.4145.9152.9737.1056.0262.5154.8749.89
General And Administrative Expense 15.7914.8216.9721.7116.9530.1315.8915.2412.095.8515.47
Operating Income Loss -37.80-23.42-33.24-54.11-27.28319.39-50.36-65.82-72.69-40.85-60.96
Interest Income Expense Nonoperating Net 5.925.055.034.834.801.731.120.440.300.300.34
Income Tax Expense Benefit 0.07-4.721.111.651.3911.01-0.03-0.01-0.07-1.370.76
Net Income Loss -31.65-14.48-28.69-51.15-24.35309.43-47.85-64.62-72.62-39.15-60.58
Comprehensive Income Net Of Tax -32.77-12.79-29.17-53.03-23.63309.43-47.85-64.62-72.62-39.15-60.58
Net Income Loss Available To Common Stockholders Basic -31.65-14.48-28.69-51.15-24.35309.43-47.85-64.62-72.62-39.15-60.58
Net Income Loss Available To Common Stockholders Diluted -31.86-14.47-28.69-51.20-24.71309.42-47.86-64.62-72.93-49.42-65.12

    2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30
Assets 553.75580.88556.37602.05600.74648.73300.26NANA389.13NA
Liabilities 115.75116.07132.02153.13127.20155.77120.50NANA140.04NA
Liabilities And Stockholders Equity 553.75580.88556.37602.05600.74648.73300.26NANA389.13NA
Stockholders Equity 438.00464.81424.34448.92473.54492.96179.76222.28282.44249.09278.93

    2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30
Assets Current 393.82412.93374.63420.34426.37544.71190.66NANA288.22NA
Cash And Cash Equivalents At Carrying Value 114.81157.5694.33142.10181.58400.9196.08NANA201.87NA
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 114.81157.5694.33142.10181.58400.9196.08198.65275.52201.87253.44
Short Term Investments NA216.77201.07197.99159.2191.3270.16NANA50.74NA
Accounts Receivable Net Current 30.9519.4867.2748.8266.9233.406.73NANA15.61NA
Prepaid Expense And Other Assets Current 17.8219.1211.9631.4318.6619.0717.69NANA20.00NA

    2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30
Property Plant And Equipment Gross NA40.50NANANA38.01NANANA36.84NA
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment NA20.66NANANA13.30NANANA14.06NA
Amortization Of Intangible Assets 0.700.670.670.680.680.530.170.170.150.15NA
Property Plant And Equipment Net 18.9719.8520.9022.3823.5124.7125.72NANA22.78NA
Long Term Investments NA82.1595.6792.2372.470.890.89NANA0.89NA
Finite Lived Intangible Assets Net 7.427.668.007.408.078.769.02NANA3.84NA

    2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30
Liabilities Current 56.8955.7672.8593.5567.3295.6257.71NANA71.85NA
Accounts Payable And Accrued Liabilities Current 47.4345.0367.7969.9259.2587.4752.27NANA62.77NA
Accrued Income Taxes Current 1.861.810.831.160.840.84NANANANANA
Contract With Customer Liability Current 3.443.700.0917.762.352.35NANANANANA

    2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30
Deferred Income Tax Liabilities Net 3.353.301.971.921.861.791.59NANA1.57NA
Other Liabilities Noncurrent 1.591.701.863.603.603.102.93NANA2.75NA
Operating Lease Liability Noncurrent 20.9822.3722.4123.4923.8524.6725.33NANA30.92NA

    2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30
Stockholders Equity 438.00464.81424.34448.92473.54492.96179.76222.28282.44249.09278.93
Common Stock Value 1003.48997.23932.14929.40900.49886.32885.35NANA741.15NA
Additional Paid In Capital Common Stock 143.14142.27154.11152.26152.68151.61169.26NANA197.71NA
Retained Earnings Accumulated Deficit -709.09-677.44-662.96-634.27-583.12-558.76-868.19NANA-683.10NA
Accumulated Other Comprehensive Income Loss Net Of Tax -7.72-6.60-8.30-7.81-5.94-6.66-6.66NANA-6.66NA
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 3.44NA2.690.742.20NA4.384.45-2.93NA10.33

    2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30
Net Cash Provided By Used In Operating Activities -37.6713.95-42.67-6.40-83.19327.36-73.02-54.82-55.41-50.51NA
Net Cash Provided By Used In Investing Activities -7.32-1.34-7.02-60.67-138.22-22.07-30.43-21.9320.57-1.86NA
Net Cash Provided By Used In Financing Activities 2.1250.611.9027.601.74-0.380.63-0.28108.610.69NA

    2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30
Net Cash Provided By Used In Operating Activities -37.6713.95-42.67-6.40-83.19327.36-73.02-54.82-55.41-50.51NA
Net Income Loss -31.65-14.48-28.69-51.15-24.35309.43-47.85-64.62-72.62-39.15-60.58
Increase Decrease In Accounts Receivable 11.47-47.8018.46-18.1033.5226.672.31-0.15-11.3210.69NA
Share Based Compensation 3.553.372.040.372.334.504.802.90-8.18-1.69NA

    2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30
Net Cash Provided By Used In Investing Activities -7.32-1.34-7.02-60.67-138.22-22.07-30.43-21.9320.57-1.86NA
Payments To Acquire Property Plant And Equipment 0.180.360.930.800.390.350.982.664.164.78NA

    2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30
Net Cash Provided By Used In Financing Activities 2.1250.611.9027.601.74-0.380.63-0.28108.610.69NA

    2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30
Revenues 10.0316.9316.517.0035.58402.492.635.441.9219.874.39
Jazz Pharmaceuticals Ireland Limited, Drug Supply 1.58NA5.390.003.53NANANANANANA
Jazz Pharmaceuticals Ireland Limited, Drug Supply For Ongoing Studies 6.22NANANA4.75NANANANANANA
Jazz Pharmaceuticals Ireland Limited, Research Support Payments And Other Service 2.07NA10.0426.5626.14NANANANANANA
Research Support Payments And Other Service 0.171.711.080.541.163.212.630.441.92NANA
Revenue From Contract With Customer Excluding Assessed Tax 10.0316.9316.517.0035.58402.492.635.441.9219.874.39
Jazz Pharmaceuticals Ireland Limited, Drug Supply 1.58NA5.390.003.53NANANANANANA
Jazz Pharmaceuticals Ireland Limited, Drug Supply For Ongoing Studies 6.22NANANA4.75NANANANANANA
Jazz Pharmaceuticals Ireland Limited, Research Support Payments And Other Service 2.07NA10.0426.5626.14NANANANANANA
Research Support Payments And Other Service 0.171.711.080.541.163.212.630.441.92NANA

Plots across concepts


IncomeStatement
Operating Income Loss
Expenses
Other Nonoperating Income Expense
Balance Sheet
Finite Lived Intangible Assets Net
Assets
Goodwill
Current Assets
Prepaid Expense And Other Assets Current
NonCurrent Assets
Deferred Income Tax Assets Net
PropertyPlantAndEquipmentNet
Property Plant And Equipment Net
Liabilities
Derivative Liabilities
Current Liabilities
Accrued Income Taxes Current
Stockholders Equity
Retained Earnings Accumulated Deficit
CashFlow
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInInvestingActivities
Net Cash Provided By Used In Investing Activities
Shares
Weighted Average Number Of Shares Outstanding Basic
OperatingLeaseLiability
Operating Lease Liability Current
NonoperatingIncomeExpense
Other Nonoperating Income Expense
LesseeOperatingLeaseLiabilityPaymentsDue
Lessee Operating Lease Liability Undiscounted Excess Amount
FiniteLivedIntangibleAssets
Finite Lived Intangible Assets Net

Line plots across dimensions of each concept